Evidence map›Paper›PMID 41048945›Full record

ArticleFrontiers in medicine2025

The burden and risk factors of chronic obstructive pulmonary disease in Asia and its countries from 1990 to 2021: a systematic analysis based on the 2021 global burden of disease study.

Zeyuan Wu, Xin Zhang, Pingxi Zhang, Yaling He, Yalin Ye, Yun Pan, Yan Li

Abstract read
In one paragraph

Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Zeyuan WuSchool of Basic Medicine, Dali University, Dali, China.
Xin ZhangSchool of Basic Medicine, Dali University, Dali, China.
Pingxi ZhangSchool of Basic Medicine, Dali University, Dali, China.
Yaling HeSchool of Basic Medicine, Dali University, Dali, China.
Yalin YeSchool of Basic Medicine, Dali University, Dali, China.
Yun PanDepartment of Pathology, The First Affiliated Hospital of Dali University, Dali, China.
Yan LiSchool of Basic Medicine, Dali University, Dali, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Chronic obstructive pulmonary disease (COPD) is a chronic respiratory disease characterized by airflow limitation that is not fully reversible. In Asia, risk exposures such as smoking and ambient PM₂.₅ are prevalent, and regional differences are significant. This has led to the COPD disease burden in this region being at a relatively high level globally. Based on this, this study conducts a systematic assessment of the COPD disease burden in Asia. Methods: Data on incidence, mortality, and disability-adjusted life years (DALYs) were obtained from the Global Burden of Disease (GBD) 2021 study. The analysis incorporated the Sociodemographic Index (SDI) and included stratification by sex and age to reveal the distribution and disparities in the burden of COPD across populations. Joinpoint regression models were used to calculate the annual percent change (APC) and average annual percent change (AAPC) to estimate temporal trends. In addition, major attributable risk factors for COPD were analyzed to identify key drivers of disease burden across regions and populations. Results: In 2021, the number of COPD cases in Asia reached 10,512,843 (95% UI: 9,610,006-11,432,970), with an age-standardized incidence rate of 210.79 per 100,000 persons (95% UI: 193.52-227.94). COPD accounted for 2,885,059 deaths (95% UI: 2,571,267-3,218,689), corresponding to an age-standardized mortality rate of 64.10 per 100,000 persons (95% UI: 56.74-71.66). The total DALYs were 60,507,100 (95% UI: 55,319,463-66,518,282), with an age-standardized rate of 1,253.15 per 100,000 persons (95% UI: 1,148.26-1,376.29). Among Asian subregions, South Asia bore the heaviest burden of COPD. Major risk factors included particulate matter (PM) pollution, smoking, secondhand smoke, and occupational exposure to particulate matter, gases, and fumes (OP-MGF). Conclusion: This study highlights the substantial COPD burden in Asia, with air pollution, smoking, and occupational exposures being the predominant risk factors. Targeted public health interventions are urgently needed to mitigate the COPD burden and improve overall health outcomes in the region.

Indexed as

chronic obstructive pulmonary disease (COPD)disease burdenJoinpoint regressionrisk factorsSocio-demographic Index (SDI)

Identifiers

PMID41048945
PMCPMC12491052

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.